Thalys Medical Technology Group (SHSE:603716) Total Liabilities: ¥753.1 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603716 Thalys Medical Technology Group Corp SHSE:603716
39 GF Score
Price ¥15.89
GF Value ¥4.70
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Thalys Medical Technology Group Total Liabilities?

Thalys Medical Technology Group SHSE:603716 +3.38% 39 Total Liabilities is ¥753.1 Mil as of Mar. 2026. GuruFocus rates SHSE:603716 with a GF Score™ of 39/100 and a GF Value™ of ¥4.70 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Thalys Medical Technology Group's Total Liabilities for the quarter that ended in Mar. 2026 was ¥753.1 Mil.

Thalys Medical Technology Group's quarterly Total Liabilities declined from Sep. 2025 (¥1,037.05 Mil) to Dec. 2025 (¥897.96 Mil) and declined from Dec. 2025 (¥897.96 Mil) to Mar. 2026 (¥753.10 Mil).

Thalys Medical Technology Group's annual Total Liabilities declined from Dec. 2023 (¥2,027.09 Mil) to Dec. 2024 (¥1,868.03 Mil) and declined from Dec. 2024 (¥1,868.03 Mil) to Dec. 2025 (¥897.96 Mil).

Thalys Medical Technology Group Total Liabilities Historical Data

* Premium members only.

The historical data trend for Thalys Medical Technology Group's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thalys Medical Technology Group Total Liabilities Chart

Thalys Medical Technology Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,550.66 2,461.91 2,027.09 1,868.03 897.96

Thalys Medical Technology Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,330.36 1,350.56 1,037.05 897.96 753.10
SHSE:603716
39GF Score
Thalys Medical Technology Group Corp SHSE:603716
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thalys Medical Technology Group Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Thalys Medical Technology Group's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=872.77+(19.389+5.175
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0.622)
=898.0

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=1802.443-904.487
=898.0

Thalys Medical Technology Group's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=725.245+(21.205+4.956
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0.622)
=753.1

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=1739.486-986.389
=753.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ¥753.1 Mil mean?
Thalys Medical Technology Group (SHSE:603716) has a Total Liabilities of ¥753.1 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Thalys Medical Technology Group and its competitors.
Is Thalys Medical Technology Group's Total Liabilities too high?
Thalys Medical Technology Group's current Total Liabilities is ¥753.1 Mil. Overall, Thalys Medical Technology Group has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Thalys Medical Technology Group's Total Liabilities compare to TMO and DHR?
Thalys Medical Technology Group's Total Liabilities of ¥753.1 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Diagnostics & Research company?
A good Total Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Thalys Medical Technology Group and its competitors. Thalys Medical Technology Group's current Total Liabilities is ¥753.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thalys Medical Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Thalys Medical Technology Group (SHSE:603716) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥4.70, compared to a current price of ¥15.89 — trading 238.1% above its estimated fair value. The current Total Liabilities is ¥753.1 Mil. Thalys Medical Technology Group's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Thalys Medical Technology Group (SHSE:603716), the current Total Liabilities is ¥753.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Thalys Medical Technology Group (SHSE:603716) Overvalued in 2026?

Based on GuruFocus' analysis, Thalys Medical Technology Group stock appears to be overvalued. The current stock price of ¥15.89 is trading 238.1% above its estimated GF Value™ of ¥4.70. GuruFocus considers Thalys Medical Technology Group to be Significantly Overvalued.

Key valuation signals for SHSE:603716:

  • Total Liabilities: ¥753.1 Mil
  • GF Value™: ¥4.70 vs. price of ¥15.89 (238.1% above fair value)
  • GF Score™: 39/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603716 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Thalys Medical Technology Group Business Description

Address 1310 Jinshan Avenue, Dongxihu District, Hubei Province, Wuhan, CHN, 430040
Thalys Medical Technology Group Corp is engaged in intensive sales business, pure sales, and research and development, production and sales of independent in vitro diagnostic products.
39GF Score

Get the complete analysis for SHSE:603716

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.89
Price
¥4.70
GF Value